Evidence map›Paper›PMID 34995112›Full record

ArticleScience advances2022

Real-time monitoring of drug pharmacokinetics within tumor tissue in live animals.

Ji-Won Seo, Kaiyu Fu, Santiago Correa, Michael Eisenstein, Eric A Appel, Hyongsok T Soh

Abstract read
In one paragraph

Article in Science advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Continuous, Week-Long, Seconds-ResolvedJournal of the American Chemical Society · 2026
    Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ji-Won SeoDepartment of Electrical Engineering, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0001-5461-994X
Kaiyu FuDepartment of Electrical Engineering, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0002-7899-0388
Santiago CorreaDepartment of Materials Science and Engineering, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0001-8230-4945
Michael EisensteinDepartment of Electrical Engineering, Stanford University, Stanford, CA 94305, USA.
Eric A AppelDepartment of Materials Science and Engineering, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0002-2301-7126
Hyongsok T SohDepartment of Electrical Engineering, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0001-9443-857X

Funding

Real-time biosensor for mapping the function of the pancreasOT2OD025342 · OD · STANFORD UNIVERSITY · PI SOH, HYONGSOK TOM · 2018 to 2021
$4.6M
Cancer immunotherapy using injectable hydrogels for precise and tunable multidrug deliveryF32CA247352 · NCI · STANFORD UNIVERSITY · PI CORREA, SANTIAGO · 2020 to 2022
$201k
NCI NIH HHS F32 CA247352NIH HHS OT2 OD025342
6 · The paper itself

Abstract

The efficacy and safety of a chemotherapy regimen fundamentally depends on its pharmacokinetics. This is currently measured based on blood samples, but the abnormal vasculature and physiological heterogeneity of the tumor microenvironment can produce radically different drug pharmacokinetics relative to the systemic circulation. We have developed an implantable microelectrode array sensor that can collect such tissue-based pharmacokinetic data by simultaneously measuring intratumoral pharmacokinetics from multiple sites. We use gold nanoporous microelectrodes that maintain robust sensor performance even after repeated tissue implantation and extended exposure to the tumor microenvironment. We demonstrate continuous in vivo monitoring of concentrations of the chemotherapy drug doxorubicin at multiple tumor sites in a rodent model and demonstrate clear differences in pharmacokinetics relative to the circulation that could meaningfully affect drug efficacy and safety. This platform could prove valuable for preclinical in vivo characterization of cancer therapeutics and may offer a foundation for future clinical applications.

Indexed as

DoxorubicinGoldAnimalsMicroelectrodesTumor MicroenvironmentDoxorubicinGold

Identifiers

PMID34995112
PMCPMC8741190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.